<DOC>
	<DOCNO>NCT01394289</DOCNO>
	<brief_summary>The objective study determine biologic activity Lolium perenne allergen extract histamine equivalent prick ( HEP ) unit , order use in-house reference preparation ( IHRP ) .</brief_summary>
	<brief_title>Biological Standardization Lolium Perenne Allergen Extract</brief_title>
	<detailed_description>Four concentration Lolium perenne allergen extract , together positive negative control , use 10 mg/ml histamine dihydrochloride solution glycerinated phenol saline solution , respectively , test every patient duplicate volar surface forearm .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine phosphate</mesh_term>
	<criteria>Subject provide write informed consent , appropriately sign date subject ( legal representative , applicable ) . Subject male female race ethnic group . Age &gt; 18 year &lt; 50 year study inclusion day . Positive skin prick test standardize commercially available preparation Lolium perenne allergen extract . The skin prick test consider positive test result wheal major diameter least 3 mm least size positive control . Positive skin prick test result valid perform within one year prior inclusion subject study A positive test specific IgE Lolium perenne ( CAPRAST ≥ 2 ) . IgE result valid perform within one year prior inclusion subject study . Allergic symptoms pollen season Lolium perenne . Mean forearm major diameter wheal provoke histamine dihydrochloride ( 10 mg/ml ) ≥ 3 mm . Immunotherapy past 5 year allergen preparation know interfere allergen test ( e.g. , grass group extract ) . Use drug may interfere skin reaction ( e.g. , antihistamine ) . See Appendix 1 Treatment follow medication : tricyclic tetracyclic antidepressant , βblockers corticosteroid ( &gt; 10 mg/day prednisone equivalent ) . Pregnancy . Dermographism affect skin area test site either study visit . Atopic dermatitis affect skin area test site either study visit . Urticaria affect skin area test site either study visit . Participation another clinical trial within last month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Standardization</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Skin prick test</keyword>
</DOC>